Detection of MET Alterations Using Cell Free DNA and Circulating Tumor Cells from Cancer Patients
Pre-Analytical and Analytical Variables of Label-Independent Enrichment and Automated Detection of Circulating Tumor Cells in Cancer Patients
Diagnostic Leukapheresis Enables Reliable Transcriptomic Profiling of Single Circulating Tumor Cells to Characterize Inter-Cellular Heterogeneity in Terms of Endocrine Resistance
PMN-MDSCs Enhance CTC Metastatic Properties through Reciprocal Interactions via ROS/Notch/Nodal Signaling
Label-Free Enrichment and Molecular Characterization of Viable Circulating Tumor Cells from Diagnostic Leukapheresis Products
Circulating Tumor Cell Clustering Shapes DNA Methylation to Enable Metastasis Seeding
Denosumab treatment is associated with the absence of circulating tumor cells in patients with breast cancer
A novel workflow to enrich and isolate patient-matched EpCAM high and EpCAM low/negative CTCs enables the comparative characterization of the PIK3CA status in metastatic breast cancer
A novel microfluidic platform for size and deformability based separation and the subsequent molecular characterization of viable circulating tumor cells